FORESIGHT DIAGNOSTICS
Foresight Diagnostics develops novel technology created to detect cancers earlier from a simple blood draw.
FORESIGHT DIAGNOSTICS
Industry:
Biotechnology Health Care
Founded:
2020-01-01
Address:
Denver, Colorado, United States
Country:
United States
Website Url:
http://www.foresight-dx.com
Total Employee:
1+
Status:
Active
Total Funding:
12.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics
Current Advisors List
Board_member
Advisor
2020-05-01
Current Employees Featured
Sandra Close Chief Operations Officer @ Foresight Diagnostics
Chief Operations Officer
2022-04-01
Maximilian Diehn Founder @ Foresight Diagnostics
Founder
David Kurtz Founder @ Foresight Diagnostics
Founder
2020-05-01
Ash Alizadeh Scientific Co-Founder @ Foresight Diagnostics
Scientific Co-Founder
2020-05-01
Jake Chabon CEO, CSO & Founder @ Foresight Diagnostics
CEO, CSO & Founder
2020-10-01
Mukul Agarwal CFO and CBO @ Foresight Diagnostics
CFO and CBO
2021-01-01
Founder
Investors List
Civilization Ventures
Civilization Ventures investment in Series A - Foresight Diagnostics
Bluebird Ventures
Bluebird Ventures investment in Series A - Foresight Diagnostics
Pear VC
Pear VC investment in Series A - Foresight Diagnostics
Sadık Ventures
Sadık Ventures investment in Series A - Foresight Diagnostics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-04 | Foresight Diagnostics Announces the Hiring of Sandra Close, Ph.D., as Chief Operations Officer |
Official Site Inspections
http://www.foresight-dx.com
- Host name: foresight.tempurl.host
- IP address: 45.32.197.53
- Location: Dallas United States
- Latitude: 32.7889
- Longitude: -96.8021
- Metro Code: 623
- Timezone: America/Chicago
- Postal: 75201
More informations about "Foresight Diagnostics"
Foresight Diagnostics - Crunchbase Company Profile
When was the last funding round for Foresight Diagnostics? Foresight Diagnostics closed its last funding round on Jul 30, 2024 from a Series B …See details»
Foresight Diagnostics Company Profile | Management and
Foresight Diagnostics Profile and History. Foresight Diagnostics is a privately-held cancer diagnostics company. The company has developed a novel liquid biopsy testing platform for …See details»
Foresight Diagnostics Provides 2025 Outlook and 2024 Year in …
Jan 8, 2025 To schedule a meeting with the Company, please contact InvestorRelations@foresight-dx.com. References: 1 Isbell, et al. ASCO 2024 . 2 Cabel, et al. …See details»
Foresight Diagnostics - 2025 Company Profile - Tracxn
Aug 17, 2021 Foresight Diagnostics - Developer of minimally-invasive liquid biopsy test for the detection of cancer. Raised a total funding of $104M over 3 rounds from 8 investors. ...See details»
Foresight Diagnostics Provides 2025 Outlook and 2024 Year in …
BOULDER, Colo., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Foresight Diagnostics (Foresight), a leader in ultra-sensitive minimal residual disease (MRD) detection technology, today provided …See details»
Foresight Diagnostics Inc. Information - RocketReach
Foresight’s cell-free DNA testing platform was developed in the labs of two prominent professors at Stanford University and is backed by several major peer-reviewed publications. The …See details»
Foresight Diagnostics 2025 Company Profile: Valuation, …
Foresight Diagnostics General Information Description. Developer of a novel diagnosis technology designed to detect cancers earlier from a simple blood sample. The company's technology uses the biological features that make …See details»
Foresight Diagnostics - Craft
Foresight Diagnostics has 5 employees at their 1 location and $58.75 m in total funding,. See insights on Foresight Diagnostics including office locations, competitors, revenue, financials, …See details»
Foresight Diagnostics: Employee Directory | ZoomInfo.com
Foresight Diagnostics is a privately-held cancer diagnostics company. The company has developed a novel liquid biopsy testing platform for the measurement of minimal residual …See details»
Pioneers in Precision Genomics | About Foresight …
Foresight CLARITY™ was developed and its performance characteristics determined by Foresight’s central laboratory. CLIA: 06D2287941 | ISO 27001-2013 Cert No. BMSC-049-2312-ISMS1012 We use cookies on our website to …See details»
Where Science Meets Ingenuity | Careers at Foresight Diagnostics
Foresight CLARITY™ was developed and its performance characteristics determined by Foresight’s central laboratory. CLIA: 06D2287941 | ISO 27001-2013 Cert No. BMSC-049-2312-ISMS1012 We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits.See details»
Foresight Diagnostics Company Overview, Contact Details
Jul 30, 2024 foresight-dx hired David Kurtz as Chief Medical Officer (CMO) and Head of Research on May 1st '24. BOULDER, Colo., May 1, 2024 /PRNewswire/ - Foresight …See details»
Foresight Diagnostics Expands Strategic Partnership with Allogene ...
Feb 27, 2025 Foresight Diagnostics ("the Company"), a leader in ultra-sensitive minimal residual disease detection technology, today announced an expanded strategic collaboration with …See details»
Foresight Diagnostics - Overview, News & Similar companies
Aug 17, 2023 Who is Foresight Diagnostics. Foresight Diagnostics is a privately-held cancer diagnostics company. The company has developed a novel liquid biopsy testing platform for …See details»
Foresight Diagnostics to Present at 43rd Annual J.P. Morgan …
Dec 18, 2024 Foresight Diagnostics, Inc. (“Foresight”) announced that CEO Jake Chabon will present at the 43rd Annual J.P. Morgan Healthcare Conference on Jan. 15.See details»
Foresight Diagnostics Provides 2025 Outlook and 2024 Year in …
Jan 8, 2025 To schedule a meeting with the Company, please contact InvestorRelations@foresight-dx.com. References: 1 Isbell, et al. ASCO 2024 2 Cabel, et al. …See details»
www.foresightdx.com
Www.foresightdx.comSee details»
4/6【NOAH】5・3両国でGHCタッグ「モリス&ダガvs拳王&憂流 …
2 days ago NOAHは6日、5・3両国大会でGHCタッグ王座戦「(王者)ジャック・モリス&ダガvs拳王&佐々木憂流迦(挑戦者)」を行うと発表した。あわせて4・11新潟、4・14後楽園2大 …See details»
Foresight Diagnostics - workinbiotech.com
Foresight Diagnostics is a cancer diagnostics company developing a novel liquid biopsy test to detect relapse sooner. Foresight’s approach is a highly sensitive liquid biopsy minimal residual …See details»
Foresight CLARITY™ Clinical Applications | Foresight Resources
Foresight CLARITY™ was developed and its performance characteristics determined by Foresight’s central laboratory. CLIA: 06D2287941 | ISO 27001-2013 Cert No. BMSC-049-2312 …See details»